Enoxaparin for Early Anticoagulation after Mitral Valve Repair
Journal Title: Cardiology and Angiology: An International Journal - Year 2015, Vol 3, Issue 4
Abstract
Introduction: Despite recent progress and technological advances, heart valve surgery remains associated with a high rate of thromboembolic complications requiring anticoagulation, which must be both safe and effective to prevent any thromboembolic or bleeding events. Objectives: The objective of this study was to verify the efficacy and the safety of Low Molecular Weight Heparin followed by vitamin K antagonists for the early anticoagulation after mitral valve repair. Patients and Methods: This work was conducted as a prospective study. We selected 120 consecutive patients who underwent mitral valve repair and received enoxaparin as bridge between continuous unfractionated heparin and fully effective vitamin K antagonist therapy. The mean age was 63.6±13.5 years (15-84 years). Results: There was no in-hospital mortality. One bleeding event (0.8%) was described: a right haemothorax drained percutaneously with transfusion and no thrombo-embolic events. Conclusion: Low molecular weight heparin enoxaparin as bridging therapy between immediate postoperative unfractionated heparin and complete efficacy of oral anticoagulants may be considered as an option for the prevention of thromboembolic events in patients recently undergoing mitral valve repair.
Authors and Affiliations
Younes Moutakiallah, Roland Henaine, Mehdi Bamous, Jacques Robin, Jean Ninet, Jean-François Obadia
Keywords
Related Articles
- EP ID EP343927
- DOI 10.9734/CA/2015/17779
- Views 62
- Downloads 0
Atypical Cardiac Autonomic Neuropathy Identified with Entropy Measures
Aims: To identify Cardiac Autonomic Neuropathy (CAN) from a range of measures extracted from Heart Rate Variability (HRV), including higher moments of RR intervals and a spectrum of entropy measures of RR intervals. Stud...
Right Atrial Myxoma Complicated by Pulmonary Thromboembolism: A Case Report and Review of Literature
Primary cardiac tumors are rare with myxoma being the most common benign cardiac tumor. They are usually sporadic, affecting left atrium and frequently occur in women. They are known to cause valvular obstruction, thromb...
Prolactin Hormone and Cardiovascular System
The Prolactin (PRL) hormone, a very ancient hormone, first discovered by Oscar Riddle and his colleagues in the late 1920s, is a 199 amino acid multifunctional polypeptide hormone, that has been found in all vertebrates...
Early or Selective Invasive Strategy in Patients with Non-ST-segment Elevation Acute Coronary Syndrome According to the Risk Factors at Presentation? An Outcome Study
Aims: Patients with acute coronary syndrome without ST segment elevation are a heterogeneous group with respect to the risk of having a major adverse cardiac event (MACE). History of diabetes mellitus (DM), chronic kidne...
Left Ventricular Hypertrophy and Incidence of Acute Coronary Heart Disease and Mortality in the Reasons for Geographic and Racial Differences in Stroke Study (REGARDS)
Objective: To examine the relationship between left ventricular hypertrophy (LVH) and the incidence of acute coronary heart disease (CHD) and mortality in the modern era. Methods: We studied 16, 390 black and white par...